Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Barry

Showing results (131-140 of 420) with videos related to

Pageof 42
Sort By:
Reviews of Infectious Diseases|September 1, 1982
Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergyR N Jones, A L Barry, C Thornsberry
The Journal of Antimicrobial Chemotherapy|November 1, 1980
In vitro evaluation of LY127935 (6050S) compared with cefotaxime, eight other beta-lactams and two aminoglycosidesA L Barry, C Thornsberry, R N Jones
Antimicrobial Agents and Chemotherapy|October 1, 1981
Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility testA L Barry, R N Jones, C Thornsberry
Diagnostic Microbiology and Infectious Disease|January 1, 1985
In vitro antimicrobial susceptibility testing using 30 microG and 75 microG U63196-E (cefpimizole AC-1370) disksR N Jones, C Thornsberry, A L Barry
Antimicrobial Agents and Chemotherapy|June 1, 1989
Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaximeR N Jones, A L Barry, C Thornsberry
American Journal of Clinical Pathology|November 1, 1985
Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzaeA L Barry, R N Jones, C Thornsberry
The Journal of Antimicrobial Chemotherapy|September 1, 1989
In-vitro studies of meropenemR N Jones, A L Barry, C Thornsberry
Antimicrobial Agents and Chemotherapy|May 1, 1988
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycinA L Barry, R N Jones, C Thornsberry
Diagnostic Microbiology and Infectious Disease|January 1, 1985
Apalcillin [PC-904]: spectrum of activity and beta-lactamase hydrolysis/inhibitionA L Barry, R N Jones, C Thornsberry
American Journal of Clinical Pathology|February 1, 1970
An improved single-disk method for testing the antibiotic susceptibility of rapidly-growing pathogensA L Barry, F Garcia, L D Thrupp
Pageof 42

Showing results (131-140 of 420) with videos related to

Sort By:
Pageof 42
Reviews of Infectious Diseases|September 1, 1982
Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergyR N Jones, A L Barry, C Thornsberry
The Journal of Antimicrobial Chemotherapy|November 1, 1980
In vitro evaluation of LY127935 (6050S) compared with cefotaxime, eight other beta-lactams and two aminoglycosidesA L Barry, C Thornsberry, R N Jones
Antimicrobial Agents and Chemotherapy|October 1, 1981
Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility testA L Barry, R N Jones, C Thornsberry
Diagnostic Microbiology and Infectious Disease|January 1, 1985
In vitro antimicrobial susceptibility testing using 30 microG and 75 microG U63196-E (cefpimizole AC-1370) disksR N Jones, C Thornsberry, A L Barry
Antimicrobial Agents and Chemotherapy|June 1, 1989
Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaximeR N Jones, A L Barry, C Thornsberry
American Journal of Clinical Pathology|November 1, 1985
Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzaeA L Barry, R N Jones, C Thornsberry
The Journal of Antimicrobial Chemotherapy|September 1, 1989
In-vitro studies of meropenemR N Jones, A L Barry, C Thornsberry
Antimicrobial Agents and Chemotherapy|May 1, 1988
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycinA L Barry, R N Jones, C Thornsberry
Diagnostic Microbiology and Infectious Disease|January 1, 1985
Apalcillin [PC-904]: spectrum of activity and beta-lactamase hydrolysis/inhibitionA L Barry, R N Jones, C Thornsberry
American Journal of Clinical Pathology|February 1, 1970
An improved single-disk method for testing the antibiotic susceptibility of rapidly-growing pathogensA L Barry, F Garcia, L D Thrupp
Pageof 42